Single Nucleotide Polymorphism Genotyping Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Transversion
1.2.3 Transition
1.3 Market by Application
1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Animal
1.3.4 Plant
1.3.5 Research
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2017-2028)
2.2 Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Region
2.2.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Region (2017-2022)
2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2023-2028)
2.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics
2.3.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
2.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
2.3.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
2.3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue
3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2017-2022)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2017-2022)
3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio
3.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2021
3.5 Single Nucleotide Polymorphism (SNP) Genotyping Key Players Head office and Area Served
3.6 Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
3.7 Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Type
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2017-2022)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2023-2028)
5 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Application
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Application (2017-2022)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2017-2028)
6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
6.2.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022)
6.2.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028)
6.2.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2017-2028)
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
6.3.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022)
6.3.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028)
6.3.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2017-2028)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
6.4.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022)
6.4.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2017-2028)
7.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
7.2.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022)
7.2.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028)
7.2.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2017-2028)
7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
7.3.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022)
7.3.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028)
7.3.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2017-2028)
7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
7.4.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022)
7.4.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2017-2028)
8.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
8.2.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2017-2028)
8.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
8.3.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2017-2028)
8.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region
8.4.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2017-2028)
9.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
9.2.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022)
9.2.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028)
9.2.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2017-2028)
9.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
9.3.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022)
9.3.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028)
9.3.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2017-2028)
9.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
9.4.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022)
9.4.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2017-2028)
10.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
10.2.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type (2017-2028)
10.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
10.3.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application (2017-2028)
10.4 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country
10.4.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.1.5 Illumina Recent Developments
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.2.5 Affymetrix Recent Developments
11.3 Applied Biosystems
11.3.1 Applied Biosystems Company Details
11.3.2 Applied Biosystems Business Overview
11.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.3.5 Applied Biosystems Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.4.5 Agilent Technologies Recent Developments
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.5.5 Beckman Coulter Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.6.5 Roche Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.7.5 Qiagen Recent Developments
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Details
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.8.5 Luminex Corporation Recent Developments
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Details
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.9.5 Enzo Life Sciences Recent Developments
11.10 Bio-rad
11.10.1 Bio-rad Company Details
11.10.2 Bio-rad Business Overview
11.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.10.5 Bio-rad Recent Developments
11.11 Sequenom
11.11.1 Sequenom Company Details
11.11.2 Sequenom Business Overview
11.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.11.5 Sequenom Recent Developments
11.12 Ocimum Biosolutions
11.12.1 Ocimum Biosolutions Company Details
11.12.2 Ocimum Biosolutions Business Overview
11.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.12.5 Ocimum Biosolutions Recent Developments
11.13 GE Healthcare
11.13.1 GE Healthcare Company Details
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.13.5 GE Healthcare Recent Developments
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.14.5 GenScript Recent Developments
11.15 Douglas Scientific
11.15.1 Douglas Scientific Company Details
11.15.2 Douglas Scientific Business Overview
11.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.15.5 Douglas Scientific Recent Developments
11.16 BGI
11.16.1 BGI Company Details
11.16.2 BGI Business Overview
11.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.16.5 BGI Recent Developments
11.17 Beijing Sunbiotech
11.17.1 Beijing Sunbiotech Company Details
11.17.2 Beijing Sunbiotech Business Overview
11.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.17.5 Beijing Sunbiotech Recent Developments
11.18 HuaGene Biotech
11.18.1 HuaGene Biotech Company Details
11.18.2 HuaGene Biotech Business Overview
11.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.18.5 HuaGene Biotech Recent Developments
11.19 Generay Biotech
11.19.1 Generay Biotech Company Details
11.19.2 Generay Biotech Business Overview
11.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.19.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.19.5 Generay Biotech Recent Developments
11.20 Benegene
11.20.1 Benegene Company Details
11.20.2 Benegene Business Overview
11.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.20.5 Benegene Recent Developments
11.21 Shanghai Biochip
11.21.1 Shanghai Biochip Company Details
11.21.2 Shanghai Biochip Business Overview
11.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.21.5 Shanghai Biochip Recent Developments
11.22 GENESKY
11.22.1 GENESKY Company Details
11.22.2 GENESKY Business Overview
11.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.22.5 GENESKY Recent Developments
11.23 HD Biosciences
11.23.1 HD Biosciences Company Details
11.23.2 HD Biosciences Business Overview
11.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
11.23.5 HD Biosciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Transversion
Table 3. Key Players of Transition
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2017-2022)
Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2023-2028)
Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
Table 12. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
Table 13. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Players (2017-2022)
Table 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2021)
Table 17. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Single Nucleotide Polymorphism (SNP) Genotyping Product Solution and Service
Table 21. Date of Enter into Single Nucleotide Polymorphism (SNP) Genotyping Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2017-2022)
Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2023-2028)
Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2017-2022)
Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Share by Application (2023-2028)
Table 31. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2023-2028) & (US$ Million)
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 64. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 65. Illumina Recent Developments
Table 66. Affymetrix Company Details
Table 67. Affymetrix Business Overview
Table 68. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 69. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 70. Affymetrix Recent Developments
Table 71. Applied Biosystems Company Details
Table 72. Applied Biosystems Business Overview
Table 73. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 74. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 75. Applied Biosystems Recent Developments
Table 76. Agilent Technologies Company Details
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 79. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 80. Agilent Technologies Recent Developments
Table 81. Beckman Coulter Company Details
Table 82. Beckman Coulter Business Overview
Table 83. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 84. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 85. Beckman Coulter Recent Developments
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 89. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 90. Roche Recent Developments
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 94. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 95. Qiagen Recent Developments
Table 96. Luminex Corporation Company Details
Table 97. Luminex Corporation Business Overview
Table 98. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 99. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 100. Luminex Corporation Recent Developments
Table 101. Enzo Life Sciences Company Details
Table 102. Enzo Life Sciences Business Overview
Table 103. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 104. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 105. Enzo Life Sciences Recent Developments
Table 106. Bio-rad Company Details
Table 107. Bio-rad Business Overview
Table 108. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 109. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 110. Bio-rad Recent Developments
Table 111. Sequenom Company Details
Table 112. Sequenom Business Overview
Table 113. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 114. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 115. Sequenom Recent Developments
Table 116. Ocimum Biosolutions Company Details
Table 117. Ocimum Biosolutions Business Overview
Table 118. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 119. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 120. Ocimum Biosolutions Recent Developments
Table 121. GE Healthcare Company Details
Table 122. GE Healthcare Business Overview
Table 123. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 124. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 125. GE Healthcare Recent Developments
Table 126. GenScript Company Details
Table 127. GenScript Business Overview
Table 128. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 129. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 130. GenScript Recent Developments
Table 131. Douglas Scientific Company Details
Table 132. Douglas Scientific Business Overview
Table 133. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 134. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 135. Douglas Scientific Recent Developments
Table 136. BGI Company Details
Table 137. BGI Business Overview
Table 138. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 139. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 140. BGI Recent Developments
Table 141. Beijing Sunbiotech Company Details
Table 142. Beijing Sunbiotech Business Overview
Table 143. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 144. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 145. Beijing Sunbiotech Recent Developments
Table 146. HuaGene Biotech Company Details
Table 147. HuaGene Biotech Business Overview
Table 148. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 149. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 150. HuaGene Biotech Recent Developments
Table 151. Generay Biotech Company Details
Table 152. Generay Biotech Business Overview
Table 153. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 154. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 155. Generay Biotech Recent Developments
Table 156. Benegene Company Details
Table 157. Benegene Business Overview
Table 158. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 159. Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 160. Benegene Recent Developments
Table 161. Shanghai Biochip Company Details
Table 162. Shanghai Biochip Business Overview
Table 163. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 164. Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 165. Shanghai Biochip Recent Developments
Table 166. GENESKY Company Details
Table 167. GENESKY Business Overview
Table 168. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 169. GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 170. GENESKY Recent Developments
Table 171. HD Biosciences Company Details
Table 172. HD Biosciences Business Overview
Table 173. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 174. HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022) & (US$ Million)
Table 175. HD Biosciences Recent Developments
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2021 VS 2028
Figure 2. Transversion Features
Figure 3. Transition Features
Figure 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2021 VS 2028
Figure 5. Diagnostics Case Studies
Figure 6. Animal Case Studies
Figure 7. Plant Case Studies
Figure 8. Research Case Studies
Figure 9. Others Case Studies
Figure 10. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
Figure 11. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region: 2021 VS 2028
Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2021
Figure 15. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2021
Figure 17. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Type (2017-2028)
Figure 19. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Application (2017-2028)
Figure 20. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Country (2017-2028)
Figure 21. United States Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Type (2017-2028)
Figure 25. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Application (2017-2028)
Figure 26. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Country (2017-2028)
Figure 27. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Region (2017-2028)
Figure 37. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Country (2017-2028)
Figure 47. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Country (2017-2028)
Figure 53. Turkey Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Illumina Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 57. Affymetrix Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 58. Applied Biosystems Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 59. Agilent Technologies Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 60. Beckman Coulter Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 61. Roche Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 62. Qiagen Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 63. Luminex Corporation Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 64. Enzo Life Sciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 65. Bio-rad Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 66. Sequenom Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 67. Ocimum Biosolutions Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 68. GE Healthcare Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 69. GenScript Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 70. Douglas Scientific Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 71. BGI Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 72. Beijing Sunbiotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 73. HuaGene Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 74. Generay Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 75. Benegene Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 76. Shanghai Biochip Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 77. GENESKY Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 78. HD Biosciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Industry Market Size
